Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Study

Evaluation of the role of the critical care pharmacist in identifying and avoiding or minimizing significant drug–drug interactions in medical intensive care patients.

Rivkin A, Yin H. Evaluation of the role of the critical care pharmacist in identifying and avoiding or minimizing significant drug-drug interactions in medical intensive care patients. J Crit Care. 2011;26(1):104.e1-6. doi:10.1016/j.jcrc.2010.04.014.

Save
Print
May 11, 2011
Rivkin A, Yin H. J Crit Care. 2011;26(1):104.e1-6.
View more articles from the same authors.

This study found that having a clinical pharmacist participate in daily rounds reduced the number of clinically important drug–drug interactions (DDIs) after therapy modification. Lower numbers of DDIs were also associated with shorter lengths of stay, suggesting a potential business case for greater pharmacist involvement in this patient population.

Save
Print
Cite
Citation

Rivkin A, Yin H. Evaluation of the role of the critical care pharmacist in identifying and avoiding or minimizing significant drug-drug interactions in medical intensive care patients. J Crit Care. 2011;26(1):104.e1-6. doi:10.1016/j.jcrc.2010.04.014.